'

Contact mail: pmi@pie.nl

Request a demo

3mensio Mitral Valve Users

What our customers say about 3mensio Structural Heart Mitral Valve

Request a demo
What our customers say about 3mensio Structural Heart Mitral Valve

What Customers Say About 3mensio Mitral Valve 

Torsten Vahl, MD (Columbia University Irving Medical Center, New York, USA)

   

"3mensio Structural Heart is used as a standard for precise procedural planning in our daily practice. The main strength of this program is its’ simplicity that allows users to become familiar with the planning of structural heart procedures in a very short period of time.

3mensio enables us to screen our patients expeditiously for potential transcatheter mitral valve replacement (TMVR). Determination of the mitral annulus size is a key component of the procedural planning. This can now be achieved across multiple phases with the automatic 3D segmentation of the mitral annulus. Once the appropriate device size is selected, a virtual valve can be placed in the predicted implant position and the neoLVOT can be assessed.

Another crucial aspect of pre-procedural evaluation for many TMVR devices is determining the location for transseptal puncture and simulation of the catheter path. Using the septal crossing workflow, the available septal height can be readily assessed. The simulated catheter path based on the specifications of the actual delivery system enables us to visualize the bending angles that may be required. Finally, the ability to predict the C-arm angulation for the implant view streamlines the procedure."

 

Hani Mahmoud-Elsayed, MD, (Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt)

   

"Preplanning for transcatheter mitral valve replacement (TMVR) is essential because of the risk of LVOT obstruction. Nowadays, the first devices are cleared for clinical use and an increasing number of devices is subject to clinical trials. LVOT and neoLVOT sizes are routinely evaluated for TMVR.

Using the 3mensio Mitral CT workflow, the mitral annulus geometry and LVOT can be easily defined. A virtual valve can be moved through the mitral annular space in all cardiac phases to assess implantation depth and neoLVOT size.

Besides preplanning, screening of patients becomes important given the increasing number of patients that could benefit from mitral valve replacement. The unique 3mensio Mitral 3D TEE workflow offers analysis of the 3D TEE dataset of the mitral valve, can quantify the mitral valve annulus, leaflets and neoLVOT. 3D TEE pre-planning could also serve as a substitute to CT if the latter is contraindicated. 3mensio Mitral 3D TEE is a promising tool for screening purposes. One interesting (future) application of the software lies in preplanning of valve-in-valve cases.

Bringing both 3D TEE and CT worlds together is straightforward with 3mensio. The registration workflow facilitates that the virtual implant of the valve is in the same position on my 3D TEE screening as it is on the CT scan that I use for preplanning."